Shopify Made a Transformative Deal With OpenAI: Is the Stock a Buy?

Shopify (TSX:SHOP) is an AI winner and shares might be too cheap to pass up given the growth catalysts in 2026 and 2027.

| More on:
A person's hand cupped open with a hologram of an AI chatbot above saying Hi, can I help you

Source: Getty Images

Key Points

  • Shopify is a highly volatile, high‑beta e‑commerce name trading at a steep ~117x trailing P/E and about 11% below its 52‑week high, so it’s risky and demands patience.
  • If you believe in management and AI‑driven merchant growth (e.g., the OpenAI tie‑up enabling in‑chat purchases), SHOP can be a long‑term buy—but only if you can ride out sharp swings.

Shares of Shopify (TSX:SHOP) have had quite the steep ups and downs over the past couple of weeks, to say the least. And while the elevated levels of volatility are a given when it comes to the e-commerce tech firm, which sports a high 2.8 beta (which has a higher correlation to the broad market), I still think that the choppy moves are worth riding out if you’re a believer in management and the long-term AI-driven growth story at hand.

With shares of Shopify sailing past Black Friday and landing in a rather difficult spot, seemingly halfway between the lows of the November correction and 52-week highs, investors must ask themselves what the path forward will be now that some growth investors are getting a bit more muted when it comes to the AI trade. Perhaps AI stories are no longer sufficient to propel the share prices of AI innovators much higher over the intermediate term.

Either way, I think long-term investors have time to wait for AI to go beyond talk. As it walks the walk, especially in the case of firms that are actively applying AI to improve various aspects of the business (think Shopify), I think there’s tremendous long-term value to be had by those willing to brave the AI-driven dips. It won’t be easy, though, especially if you keep hearing the term “bubble” being thrown out ad nauseam. In any case, I think Shopify stands out as a potential AI value play going into the new year.

Don’t forget about the potential for AI-driven sales!

With a smart deal in place with OpenAI, announced just a few months ago, I think investors are forgetting the potential impact of the technology on Shopify’s growth profile. Of course, OpenAI has not been a source of bullishness of late.

Arguably, investors have gotten quite bearish on the name, probably because ChatGPT is running the risk of falling behind. Either way, OpenAI has its fair share of issues, which, I believe, will not weigh down Shopify. At the end of the day, Shopify can partner with just about any AI, especially as models become more commoditized and the AI benchmarks change with time. In a prior piece, I highlighted the OpenAI deal as a low-risk opportunity that could accompany high rewards. I haven’t changed my tune since the announcement of the exciting collab.

As Shopify looks to allow for products to be sold directly through ChatGPT, I do think potential merchant sales could be markedly higher over the next year, especially as shopping through chatbots becomes more of a thing. I think it’s the start of a rising trend. Even if it doesn’t become the new way people shop, Shopify might not have all too much to lose anyway, given it enables merchants to sell on its incredible platforms, which are becoming better and easier to build as new AI tools come to be.

Bottom line

Though it could take some time for AI sales to blast off, I do think that long-term investors have plenty of incentive to be patient, especially as we hear less about Shopify’s long-term AI potential. At the time of this writing, SHOP stock is a bit on the pricey side at over 117 times trailing price-to-earnings (P/E). However, I think the 11% discount to 52-week highs is worth pursuing as long as you’re willing to not be frightened out of the name by the next volatility spike.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Shopify. The Motley Fool has a disclosure policy.

More on Tech Stocks

Rocket lift off through the clouds
Tech Stocks

2 Growth Stocks Set to Skyrocket in 2026 and Beyond

Growth stocks like Blackberry and Well Health Technologies are looking forward to leveraging strong opportunities in their respective industries.

Read more »

Happy golf player walks the course
Tech Stocks

The January Reset: 2 Beaten-Down TSX Stocks That Could Stage a Comeback

A January TFSA reset can work best with “comeback” stocks that still have real cash engines, not just hype.

Read more »

investor looks at volatility chart
Tech Stocks

1 Magnificent Canadian Tech Stock Down 38% to Buy and Hold for Decades

Constellation Software is a TSX tech stock that offers significant upside potential to shareholders over the next 12 months.

Read more »

AI concept person in profile
Tech Stocks

Tech’s January Bounce: 2 Canadian Stocks That Could Lead a 2026 Rebound

A January tech bounce can happen fast when fresh money and improving mood push investors back into overlooked Canadian names.

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

2 Stocks Retirees Should Absolutely Love

Discover strategies for managing stocks during retirement, especially in light of market uncertainties and downturns.

Read more »

Canada Day fireworks over two Adirondack chairs on the wooden dock in Ontario, Canada
Tech Stocks

Down 38%, This Magnificent Canadian Stock Could Be the Biggest Bargain on the TSX Today

Constellation Software (TSX:CSU) was a tough hold in 2025, could the new year be a turning point.

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

Meet the Canadian Semiconductor Stock Up 150% This Year

Given its healthy growth outlook and reasonable valuation, 5N Plus would be a compelling buy at these levels.

Read more »

money goes up and down in balance
Tech Stocks

1 Magnificent Canadian Stock Down 26% to Buy and Hold Forever

Lightspeed isn’t the pandemic high-flyer anymore and that reset may be exactly what gives patient investors a better-risk, better-price entry…

Read more »